Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-VEGF Therapy”

Showing 3 of 0 results

Not applicableStudy completedNCT05208931
What this trial is testing

Development of an Optimal Algorithm for the Management of Patients With Retinal Pigment Epithelium Detachment in Neovascular Age-related Macular Degeneration Using Artificial Intelligence

Who this might be right for
Neovascular Age-related Macular Degeneration
The S.N. Fyodorov Eye Microsurgery State Institution 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT01217931
What this trial is testing

Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial

Who this might be right for
Kidney Cancer
M.D. Anderson Cancer Center 180
Early research (Phase 1)Ended earlyNCT00426829
What this trial is testing

Proton Therapy and Bevacizumab for Primary Liver Tumors

Who this might be right for
Liver CancerHepatocellular CarcinomaCholangiocarcinoma
M.D. Anderson Cancer Center 3

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation